Entries from April 2022 ↓

pinboard April 30, 2022

Digest powered by RSS Digest

pinboard April 29, 2022

Digest powered by RSS Digest

pinboard April 28, 2022

  • AI Transformer Inventors Launch Adept with $65M to Lend a Hand to Knowledge Workers | Business Wire
    Adept was founded by a team with deep roots in large-scale neural networks. David Luan (CEO) led Google’s large model program, and before that was head of engineering at OpenAI. Ashish Vaswani (Chief Scientist) and Niki Parmar (CTO) are former Google Brain researchers and inventors of the Transformer, a model architecture that dramatically improved the way computers understand natural language. Since their invention in 2017, Transformers have unlocked decades-old problems in rapid succession – powering groundbreaking applications like GPT-3, a model that can generate human-like language such as tweets, emails, and trivia questions.

    While at Google, Ashish, Niki, and David trained bigger and bigger Transformers, with the goal of eventually building a model that could power all ML use cases. Along the way, the team discovered a major limitation: models like GPT-3 can write great prose, but they can’t take actions in the digital world.

    “Transformers and their applications represent the single largest step towards general intelligence in recent history. But we believe true general intelligence requires Transformers that can act – not just read and write,” said David Luan, CEO and Co-founder of Adept. “At Adept, we’re training a model to use every software tool and API that people use today. ”

    Users will work hand-in-hand with Adept’s technology, using a natural language interface to use existing software like Airtable, Photoshop, an ATS, Tableau, and Twilio. Adept sees this product vision as a practical path to general intelligence that puts people in the driver’s seat, enabling people to offload manual tasks and free up time for the work they most enjoy.

    “Machine learning has undergone significant advances in the last few years since the Transformer came out in 2017, and Adept’s team has literally invented it along with several other breakthroughs. There are few startups with the same level of technical capability in AI,” said Saam Motamedi, partner at Greylock and board member at Adept. “We’re excited to see Adept drive the next wave of advances through their integrated approach to research and product – pushing the frontier of generally capable models while creating tremendous user and business value.”

Digest powered by RSS Digest

pinboard April 27, 2022

  • Effective anti-COVID drug available in Washington for eligible patients | Washington State Department of Health
    OLYMPIA – Thousands of doses of a potentially life-saving COVID-19 drug are available in the state of Washington, and could potentially benefit those at highest risk for hospitalization and death from COVID-19.

    Evusheld (tixagevimab co-packaged with cilgavimab) is a monoclonal antibody treatment that can provide protection against COVID-19. Provided via injection, it can be given to adults and children 12 years and older before infection with COVID-19. At present, those eligible to receive Evusheld include people who are moderately to severely immunocompromised or have had a severe allergic reaction to a COVID-19 vaccine.

    Individuals interested in this treatment should talk to their health care provider to determine if they are eligible for Evusheld. If they are, they can work with their providers to find a facility where they can receive the injection.

  • The Go Programming Language and Environment | May 2022 | Communications of the ACM

Digest powered by RSS Digest

pinboard April 26, 2022

Digest powered by RSS Digest

pinboard April 25, 2022

Digest powered by RSS Digest

pinboard April 24, 2022

Digest powered by RSS Digest

pinboard April 23, 2022

Digest powered by RSS Digest

pinboard April 22, 2022

Digest powered by RSS Digest

pinboard April 21, 2022

Digest powered by RSS Digest